Conference Archive

PharmaTech 2025: The Future of Pharmaceutics and Drug Innovations

Theme: The Future of Pharmaceutics and Drug Innovations

28 June 2025 Bali, Indonesia, Virtual

Registration Closed Abstract Closed Contact Us Back to All Conferences

Sessions 10

Speakers 21

Sponsors 7

Venue Bali, Indonesia

About This Conference

Welcome to PharmaTech 2025: The Future of Pharmaceutics and Drug Innovations

We are excited to invite researchers, healthcare professionals, policymakers, and industry leaders from around the world to participate in PharmaTech 2025, scheduled to be held on August 26 & 27, 2025 in Bali, Indonesia. This conference aims to provide a comprehensive platform to explore the latest advancements in pharmaceutics, drug innovations, and the future of pharmaceutical sciences.

About PharmaTech 2025
PharmaTech 2025 aims to bring together professionals from various disciplines to engage in thought-provoking discussions and share cutting-edge research in pharmaceutical sciences. The conference will cover a wide array of topics, including:

Pharmaceutical Drug Development and Formulation
Drug Delivery Systems and Nanotechnology
Emerging Trends in Biotechnology and Bio-pharmaceuticals
Pharmacovigilance and Drug Safety
Regulatory Affairs and Compliance
Clinical Trials and Pharmaceutical Research
Personalized Medicine and Advanced Therapeutics
Sustainability in the Pharmaceutical Industry

Theme of the Conference
Innovating the Future of Pharmaceutics: From Drug Discovery to Global Healthcare Solutions

Why Attend PharmaTech 2025?
Join us at Pharmatech 2025 to:

Learn: Gain insights from keynote lectures, expert panels, and presentations on the latest innovations and research in the pharmaceutical industry.
Network: Connect with researchers, clinicians, policymakers, and industry experts in pharmaceutics and drug innovation.
Collaborate: Explore opportunities for collaboration and partnerships to address global healthcare challenges.
Publish: Selected papers will have the opportunity to be published in conference proceedings and high-impact journals.

Call for Abstracts and Papers
We invite researchers and industry professionals to submit abstracts and full papers on topics related to pharmaceutics and drug innovations. Submissions will undergo a rigorous peer-review process by an international scientific committee.

Note
The conference proceedings of Pharmatech 2025 will be evaluated for inclusion in Pubmed, Web of Science, SCOPUS, and other reputable indexing services. This indexing ensures global visibility and academic recognition for contributors, facilitating the widespread dissemination of research presented at the conference.

Venue
PharmaTech 2025 will take place at a luxurious venue in Bali, Indonesia, providing excellent facilities for scholarly discussions, networking, and collaboration. Bali’s scenic beauty offers a serene and conducive environment for such an impactful conference.

Contact Information
For inquiries about PharmaTech 2025, including sponsorship opportunities and registration details, please contact us at contact@srcmeetings.com. We look forward to welcoming you to an enriching and impactful conference.

Register Now
Secure your participation in PharmaTech 2025 by registering early. Be part of the innovation that shapes the future of pharmaceutics and drug development.

Note the Dates:

Register Early & Save
Submit Your Abstract Today

Important Dates:

Final Round of Abstract Submission Closes: August 01, 2025
Final Registration Closes: August 25, 2025

Call for Papers
Researchers and practitioners are invited to submit their original research contributions to PharmaTech. We welcome submissions of full papers, work-in-progress papers, and posters on topics related to Pharmaceutics. Submissions will undergo a rigorous review process by the international technical program committee.

Note: The conference proceedings of PharmaTech -2025 will be evaluated for inclusion in Pubmed, Web of Science Book Citation Index (BkCI), SCOPUS, and other reputable indexing services (Terms & Conditions apply)*. This indexing ensures extensive visibility and academic recognition for contributors, facilitating the widespread dissemination of research presented at the conference to a global audience of researchers and scholars.

Honorarium:
We are pleased to offer honorariums to our esteemed keynote and invited speakers. To qualify for an honorarium, speakers must secure a minimum of 5 paid registrations or group paid registrations from their students, colleagues, or peers. The amount of the honorarium will be determined based on the number of registrations obtained. We encourage our speakers to actively promote the conference within their networks to ensure a rewarding experience for all.

Accommodation:
Accommodation facilities can be booked through the conference for speakers who have confirmed their registration. These arrangements will only be available to conference registrants. Our team will provide assistance with booking accommodations at the conference venue hotel once registration is confirmed. Please note that accommodations are subject to availability.

Travel:
Due to limited budget resources, we regret to inform you that the conference is unable to sponsor or cover travel expenses for any participant, including speakers. We encourage speakers to make their own travel arrangements and plan accordingly.

Important Note:
Please note that this conference is organized independently without sponsorship or support from any external organizations. The registration fees are primarily used to cover the cost of amenities and services provided to our registered members, including lunch, snacks, sessions, networking opportunities, and other event-related activities. We appreciate your understanding and support.

Sessions

Conference sessions

Browse the current session list for PharmaTech 2025: The Future of Pharmaceutics and Drug Innovations.

Total Sessions 10

Regulatory Challenges with Personalized Medicine

Regulation of Personalized Therapies: As personalized medicine becomes more common, there are unique regulatory challenges, especially in genetic testing, companion diagnostics, and targeted therapies.
Data Privacy and Ethics: Addressing concerns around patient data privacy, especially when using genetic and health data to tailor drug treatments.

Blockchain for Drug Traceability and Supply Chain

Securing the Pharmaceutical Supply Chain: How blockchain technology can be applied to drug traceability, ensuring transparency, minimizing fraud, and enhancing patient safety in the global pharmaceutical supply chain.
Regulatory Implications of Blockchain: A look at how regulators are approaching blockchain for drug verification and its potential to improve compliance and regulatory oversight.

Navigating Regulatory Complexity in Pharma 2025

The regulatory landscape is evolving rapidly with the introduction of new technologies and therapeutic modalities. This session will provide an in-depth analysis of the regulatory challenges and opportunities associated with emerging drugs, biologics, gene therapies, and digital health solutions.

Key Topics:

Regulatory strategies for the approval of gene therapies and biologics
Digital health regulations and the integration of AI in clinical trials
International regulatory frameworks and harmonization efforts

Artificial Intelligence in Drug Discovery: Shaping the Future of R&D

Artificial Intelligence (AI) has emerged as a transformative force in pharmaceutical research and development. This session will focus on the integration of AI in drug discovery, from computational modeling to preclinical testing. Discussions will include the potential of AI to streamline the R&D process, enhance predictive capabilities, and reduce drug development timelines and costs.

Key Topics:

AI-driven drug design and optimization techniques
Application of machine learning in biomarker discovery and clinical trials
Ethical and regulatory considerations in the use of AI in drug development

The Future of Biologics: Advancements in Biopharmaceuticals and Biosimilars

Biologics are revolutionizing treatment options, especially in the fields of oncology and immunology. This session will discuss the progress and challenges surrounding biologics, including the rise of biosimilars and the promise of next-generation biopharmaceuticals.

Key Topics:

Development and regulation of biologics and biosimilars
Biopharmaceutical manufacturing innovations
Clinical applications and patient access to biologic therapies

Regulatory Landscape in Pharma 2025: Navigating Complexities and Compliance

As new technologies emerge, so too do the regulatory challenges they present. This session will explore how pharma companies can navigate evolving regulations, including digital health solutions, AI in clinical trials, and gene therapies.

Key Topics:

Regulatory trends for digital health and AI-based therapies
Navigating the approval process for gene and cell therapies
International regulations and compliance in a global market

Advancing Vaccines: Next-Generation Platforms and Global Health

Following the global COVID-19 pandemic, vaccine development has entered a new era. This session will highlight new vaccine platforms, including mRNA technology, and explore how these innovations are transforming the global vaccine landscape.

Key Topics:

mRNA vaccine technology and its broader applications
Challenges in global vaccine distribution and access
Future of vaccine development for infectious diseases and cancer

Nanotechnology in Drug Delivery: Precision and Efficiency

Nanotechnology promises to enhance drug delivery systems, improving bioavailability, targeting, and minimizing side effects. This session will cover the latest innovations in nanomedicine and how nanoparticles are being engineered to deliver drugs more effectively.

Key Topics:

Nanoparticle-based drug carriers and their clinical applications
Innovations in targeted drug delivery for oncology and rare diseases
Safety, toxicity, and regulatory hurdles in nanomedicine

Gene Editing Technologies: The Future of Targeted Therapies

Gene editing technologies such as CRISPR are unlocking unprecedented potential in the treatment of genetic disorders and diseases. This session will dive into the latest advancements in gene therapy, ethical concerns, and the role of CRISPR in drug development.

Key Topics:

CRISPR and gene editing for personalized therapies
Regulatory challenges in gene-based therapies
Future outlook and clinical applications of gene editing

AI in Drug Discovery: Revolutionizing Research and Development

Artificial Intelligence is rapidly transforming the landscape of drug discovery, reducing time, cost, and risk in the development of new therapies. This session will explore how AI models and deep learning techniques are revolutionizing the way we approach target identification, compound screening, and clinical trials.

Key Topics:

AI-driven drug design and compound optimization
Machine learning applications in personalized medicine
Ethical considerations and AI regulation in pharma

Submit Abstract

Abstract submission is closed

This conference is archived, so new abstract submissions are no longer accepted.

Submit Abstract Closed

Registration

Registration details

Registration windows, pricing categories, and key dates for this conference.

Currency USD

Registration is closed because this conference has already been completed.

Archived conferences remain available for review, but new registrations are disabled.

Speakers

Featured speakers

Keynote, session, and delegate speakers currently associated with this conference.

Total Speakers 20

Speaker biography will be updated soon.

He received his PhD from the North West Cancer Research Institute at Bangor University in the UK, Professor Alzahrani has published extensively and plays an active role in national research initiatives that address he...

Community Health and Development, Disease Surveillance and Response, Data Collection, Analysis, and Visualization for Health Interventions

first edition published by the Medical and Research Publications in 2021) and the United States of America version (367 pages, second edition published by the Science and Education Publishing in 2022)., he has been ho...

Speaker biography will be updated soon.

Designed and led a research study exploring knowledge, practice, attitudes and barriers toward clinical pharmacy in primary health care, Developed study protocol, collected and analyzed qualitative and quantitative da...

Speaker biography will be updated soon.

Life Member, Research Society for Study of Diabetes in India (RSSDI), Conducted in-depth research on Mucormycosis, particularly during the COVID-19 pandemic, contributing to the understanding and treatment protocols f...

Dr. Abdulmohsen H. Alrohaimi’s research interests include pharmacogenetics, nanomedicine-based drug delivery, stem cell techniques, and biotechnology. He is also focused on clinical trials infrastructure, post-marketi...

he has graduate diplomas in Clinical Research and Applied and Industrial Biotechnology. Dr. Bhaumik has contributed significantly to pharmaceutical sciences through his authorship and patent holdings. He has authored...

• X-RAY CRYSTALLOGRAPHY(small molecules as well as protein molecules) • MOLECULAR MODELLING (Docking, QSAR, MD simulation and Fee energy estimations) • QUANTUM MECHANICAL CALCULATIONS(ab-initio, semi-empirical and DFT...

Rashid Mahmood studied Analytical Chemistry and has completed his MS in Total Quality Management from Punjab University Lahore-Pakistan. He joined Pharmaceutical Industry in 2004 and immediately excelled in his execut...

Environmental aerobic and anaerobic treatment processes Biotechnology Environmental Microbiology Environmental ecotoxicity Nano-composites Photocatalytic treatment of toxic compounds Treatment of micropollutants

Isolation, semi-synthesis, and biological activities evaluation of natural products Synthesis of hydrogel for biomedical applications Synthesis of biodegradable gene/drug delivery systems

The Faculty of Pharmacy at Al- Wataniya Private University also supports scientific research, as it is equipped with the latest laboratories and scientific research equipment. It has provided all research tools and mo...

She has contributed to multiple research projects, published several peer-reviewed papers, and presented her work at numerous national and international conferences Her primary area of research lies in neuropharmacolo...

Prof Dr. Emara has been involved in successful academic research in several drugs of abuse as well as several environmental toxicities. Passionate about education and research, Prof. Emara continues to inspire the nex...

Speaker biography will be updated soon.

Prof. AlGhananeem has been involved in successful academic-industrial research collaboration initiatives that culminated in several USA FDA-approved drugs, including Revonto™ injection, Lucemyra™ tablets, Subsys™ subl...

Speaker biography will be updated soon.

OCM

Organizing committee members

Conference leadership and organizing contacts currently available in the system.

Committee Members 1

Venue

Bali, Indonesia

Virtual

Bali, Indonesia

City Virtual

Attractions 0

Nearby attractions will be added soon.

Exhibition & Sponsorship

Showcase, partners, and publishing resources

Browse exhibition highlights, sponsor visibility, and supporting journal links for this conference.

Resources 7

Partners

Event sponsors

Shagra University

Abeer AlGhananeem

Thach Ut Dong

Attapon Cheepsattayakorn

Al-Wataniya Private University

Tanta University

Dokuz eylul university

Organizer